Executive record

Andrew Kucharchuk

Public governance roles and source-backed Claims for this individual.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:andrew-kucharchukVersion: public-0As of: 2026-09-30

Not yet claimed8 published Claims5 sources

Key Claims

Biography

CFO since inception and CFO of Range I since June 2025. Currently serves as CFO of Cero Therapeutics (Nasdaq: CERO). Previously CFO of Theralink Technologies and served as CEO/CFO of OncBioMune. Graduate of Louisiana State University and Tulane University Freeman School of Business with MBA in Finance.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. 2026 to end not publishedExecutive title: Chief Financial Officer · Organization not publishedCBGGF 10-K executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

5 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. CBGGF 10-K executive officers

    sec filing · Source published: Apr 1, 2026 · Retrieved: May 16, 2026

    Supports 2 claims
    • Executive company: Executive at Chain Bridge I · Claim reviewed: Jul 28, 2026
    • Executive title: Executive title: Chief Financial Officer · Claim reviewed: Jul 28, 2026

  2. CBRGF 10-K executive officers

    sec filing · Source published: Apr 1, 2026 · Retrieved: Jul 28, 2026

    Supports 2 claims
    • Executive company: Executive at Chain Bridge I · Claim reviewed: Jul 28, 2026
    • Executive title: Executive title: Chief Financial Officer · Claim reviewed: Jul 28, 2026

  3. CBRRF 10-K executive officers

    sec filing · Source published: Apr 1, 2026 · Retrieved: Jul 28, 2026

    Supports 2 claims
    • Executive company: Executive at Chain Bridge I · Claim reviewed: Jul 28, 2026
    • Executive title: Executive title: Chief Financial Officer · Claim reviewed: Jul 28, 2026

  4. RNGT 10-K executive officers

    sec filing · Source published: Mar 25, 2026 · Retrieved: May 16, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Range Capital Acquisition Corp II · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Financial Officer · Claim reviewed: Jul 28, 2026
    • Other Company Role: Andrew Kucharchuk is also linked to Cero Therapeutics, Inc as Chief Financial Officer. · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  5. RANG 10-K executive officers

    sec filing · Source published: Mar 25, 2026 · Retrieved: May 16, 2026

    Supports 2 claims
    • Executive company: Executive at Range Capital Acquisition Corp. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Financial Officer · Claim reviewed: Jul 28, 2026